|
|
Volumn 327, Issue 5970, 2010, Pages
|
|
Treatment as prevention
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
GAG PROTEIN;
MEMBRANE LIPID;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DISEASE CONTROL;
DISEASE TRANSMISSION;
DRUG RESISTANCE;
EPIDEMIC;
HEALTH POLICY;
HEALTH RISK;
HEALTH SERVICES;
HUMAN IMMUNODEFICIENCY VIRUS;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CELL MEMBRANE;
CLINICAL EVALUATION;
CONFERENCE PAPER;
DISEASE CONTROL;
DRUG EFFICACY;
DRUG USE;
EPIDEMIC;
GENE SEQUENCE;
HEALTH PROGRAM;
HETEROSEXUALITY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NATIONAL HEALTH ORGANIZATION;
PRIORITY JOURNAL;
PROPHYLAXIS;
RISK REDUCTION;
VIRUS MORPHOLOGY;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
ENDOCYTOSIS;
ENDOSOME;
NOTE;
PHYSIOLOGY;
VIROLOGY;
VIRUS ENTRY;
VIRUS RELEASE;
DISEASE TRANSMISSION;
DRUG EFFECT;
MASS SCREENING;
VIRUS LOAD;
ENDOCYTOSIS;
ENDOSOMES;
GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;
HIV;
HUMANS;
MEMBRANE LIPIDS;
MEMBRANE MICRODOMAINS;
VIRUS INTERNALIZATION;
VIRUS RELEASE;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
HIV INFECTIONS;
MASS SCREENING;
VIRAL LOAD;
|
|
EID: 77749254770
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.327.5970.1196-b Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (0)
|
